Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 21 | 2023 | 3310 | 3.110 |
Why?
|
Seizures | 21 | 2023 | 2859 | 2.180 |
Why?
|
Epilepsy, Generalized | 4 | 2022 | 174 | 1.930 |
Why?
|
Anticonvulsants | 8 | 2022 | 1916 | 1.260 |
Why?
|
Epilepsies, Partial | 5 | 2020 | 436 | 1.200 |
Why?
|
Electroencephalography | 25 | 2023 | 6150 | 1.200 |
Why?
|
Epilepsy, Temporal Lobe | 4 | 2023 | 403 | 1.150 |
Why?
|
Catatonia | 2 | 2019 | 158 | 1.100 |
Why?
|
Epilepsy, Frontal Lobe | 2 | 2013 | 26 | 0.830 |
Why?
|
Sleep | 8 | 2023 | 4623 | 0.690 |
Why?
|
Neuroleptic Malignant Syndrome | 1 | 2019 | 71 | 0.650 |
Why?
|
Acetamides | 2 | 2017 | 249 | 0.640 |
Why?
|
Dementia | 5 | 2023 | 2518 | 0.590 |
Why?
|
Delusions | 1 | 2018 | 300 | 0.560 |
Why?
|
Psychomotor Agitation | 1 | 2018 | 293 | 0.560 |
Why?
|
Hallucinations | 1 | 2018 | 360 | 0.550 |
Why?
|
Isoxazoles | 1 | 2017 | 216 | 0.530 |
Why?
|
Mental Recall | 2 | 2023 | 1205 | 0.500 |
Why?
|
Limbic Encephalitis | 1 | 2014 | 34 | 0.490 |
Why?
|
Aging | 3 | 2019 | 8664 | 0.490 |
Why?
|
Meningitis, Cryptococcal | 1 | 2015 | 63 | 0.490 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 841 | 0.480 |
Why?
|
Apomorphine | 2 | 2010 | 150 | 0.480 |
Why?
|
Dizocilpine Maleate | 2 | 2010 | 176 | 0.470 |
Why?
|
Monitoring, Ambulatory | 1 | 2017 | 355 | 0.460 |
Why?
|
Galvanic Skin Response | 1 | 2015 | 349 | 0.450 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1061 | 0.450 |
Why?
|
Brain Waves | 2 | 2017 | 401 | 0.450 |
Why?
|
Neurosurgical Procedures | 3 | 2013 | 2002 | 0.410 |
Why?
|
Malformations of Cortical Development | 2 | 2013 | 200 | 0.410 |
Why?
|
Speech Disorders | 1 | 2013 | 189 | 0.400 |
Why?
|
Fatigue | 1 | 2018 | 1531 | 0.380 |
Why?
|
Brain | 8 | 2022 | 26385 | 0.380 |
Why?
|
Cerebral Cortex | 4 | 2020 | 5708 | 0.380 |
Why?
|
Epilepsy, Absence | 1 | 2009 | 48 | 0.350 |
Why?
|
Epilepsy, Rolandic | 1 | 2010 | 50 | 0.350 |
Why?
|
Alzheimer Disease | 4 | 2023 | 8037 | 0.340 |
Why?
|
Nucleus Accumbens | 1 | 2010 | 366 | 0.320 |
Why?
|
Mood Disorders | 1 | 2014 | 1106 | 0.310 |
Why?
|
Employment | 1 | 2014 | 1132 | 0.300 |
Why?
|
Neuralgia | 2 | 2010 | 570 | 0.300 |
Why?
|
Magnetic Resonance Imaging | 8 | 2020 | 35421 | 0.280 |
Why?
|
Retrospective Studies | 19 | 2023 | 77449 | 0.270 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3057 | 0.260 |
Why?
|
Educational Status | 2 | 2023 | 2540 | 0.260 |
Why?
|
Humans | 53 | 2023 | 744343 | 0.250 |
Why?
|
Brain Diseases | 1 | 2013 | 1563 | 0.240 |
Why?
|
Cognition | 2 | 2019 | 6770 | 0.240 |
Why?
|
Heart Rate | 1 | 2015 | 4091 | 0.240 |
Why?
|
Psychotic Disorders | 1 | 2018 | 3046 | 0.230 |
Why?
|
Anxiety Disorders | 1 | 2014 | 2690 | 0.220 |
Why?
|
Autonomic Nervous System | 2 | 2020 | 671 | 0.220 |
Why?
|
Aged | 17 | 2023 | 163280 | 0.220 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2133 | 0.210 |
Why?
|
Wrist | 2 | 2020 | 224 | 0.210 |
Why?
|
Female | 35 | 2023 | 380194 | 0.210 |
Why?
|
Male | 31 | 2023 | 350118 | 0.200 |
Why?
|
Postoperative Complications | 3 | 2013 | 15295 | 0.200 |
Why?
|
Middle Aged | 21 | 2023 | 213383 | 0.190 |
Why?
|
Motor Activity | 1 | 2010 | 2714 | 0.180 |
Why?
|
Photoplethysmography | 1 | 2020 | 56 | 0.180 |
Why?
|
Disease Progression | 3 | 2017 | 13284 | 0.170 |
Why?
|
Adult | 22 | 2023 | 214055 | 0.170 |
Why?
|
Piracetam | 2 | 2017 | 87 | 0.170 |
Why?
|
Cognition Disorders | 1 | 2013 | 4043 | 0.160 |
Why?
|
Neuropsychiatry | 1 | 2018 | 55 | 0.160 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 3587 | 0.160 |
Why?
|
Amyloid | 1 | 2023 | 795 | 0.150 |
Why?
|
Young Adult | 9 | 2018 | 56430 | 0.150 |
Why?
|
Consciousness | 1 | 2022 | 572 | 0.150 |
Why?
|
Finland | 1 | 2018 | 602 | 0.150 |
Why?
|
Psychophysiologic Disorders | 2 | 2018 | 228 | 0.150 |
Why?
|
Actigraphy | 1 | 2020 | 488 | 0.140 |
Why?
|
Polysomnography | 3 | 2020 | 1776 | 0.140 |
Why?
|
Myoclonus | 1 | 2017 | 104 | 0.140 |
Why?
|
Health Education | 1 | 2023 | 1056 | 0.140 |
Why?
|
Status Epilepticus | 1 | 2021 | 444 | 0.140 |
Why?
|
Neuropsychological Tests | 3 | 2019 | 6993 | 0.140 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57776 | 0.130 |
Why?
|
Deep Brain Stimulation | 1 | 2023 | 748 | 0.130 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18029 | 0.130 |
Why?
|
Dizziness | 1 | 2017 | 251 | 0.120 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2014 | 142 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6234 | 0.120 |
Why?
|
Trail Making Test | 1 | 2013 | 57 | 0.110 |
Why?
|
Memory | 1 | 2023 | 2174 | 0.110 |
Why?
|
Adolescent | 9 | 2021 | 85781 | 0.110 |
Why?
|
Regression Analysis | 2 | 2013 | 6459 | 0.110 |
Why?
|
Postural Balance | 1 | 2017 | 620 | 0.110 |
Why?
|
Microglia | 1 | 2020 | 1266 | 0.110 |
Why?
|
Aphasia | 1 | 2013 | 179 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2017 | 752 | 0.100 |
Why?
|
Recurrence | 2 | 2014 | 8340 | 0.100 |
Why?
|
Gait | 1 | 2017 | 793 | 0.100 |
Why?
|
Conversion Disorder | 1 | 2015 | 205 | 0.100 |
Why?
|
Association Learning | 1 | 2013 | 224 | 0.100 |
Why?
|
Mononeuropathies | 1 | 2010 | 14 | 0.100 |
Why?
|
Verbal Learning | 1 | 2013 | 467 | 0.090 |
Why?
|
Child | 7 | 2021 | 77709 | 0.090 |
Why?
|
Death, Sudden | 1 | 2012 | 302 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2018 | 1827 | 0.090 |
Why?
|
Executive Function | 1 | 2019 | 1364 | 0.090 |
Why?
|
tau Proteins | 1 | 2019 | 1868 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39050 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 895 | 0.080 |
Why?
|
Down Syndrome | 1 | 2017 | 880 | 0.080 |
Why?
|
Scalp | 2 | 2022 | 380 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 3923 | 0.080 |
Why?
|
Drug Resistance | 1 | 2014 | 1609 | 0.080 |
Why?
|
Attention | 1 | 2019 | 2400 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1588 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2011 | 1530 | 0.080 |
Why?
|
Nerve Growth Factors | 1 | 2010 | 574 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1738 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1107 | 0.070 |
Why?
|
Heart Arrest | 1 | 2017 | 1470 | 0.070 |
Why?
|
Headache | 1 | 2015 | 1226 | 0.070 |
Why?
|
Child, Preschool | 3 | 2018 | 41006 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3743 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40075 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2014 | 13989 | 0.070 |
Why?
|
Pilot Projects | 2 | 2016 | 8324 | 0.070 |
Why?
|
Random Allocation | 1 | 2010 | 2429 | 0.070 |
Why?
|
Functional Laterality | 1 | 2013 | 2290 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2494 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1813 | 0.070 |
Why?
|
Cohort Studies | 4 | 2018 | 40561 | 0.070 |
Why?
|
Video Recording | 1 | 2009 | 949 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.060 |
Why?
|
Circadian Rhythm | 2 | 2020 | 2624 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.060 |
Why?
|
Prospective Studies | 3 | 2021 | 53288 | 0.060 |
Why?
|
Syndrome | 1 | 2009 | 3251 | 0.060 |
Why?
|
Infant | 2 | 2018 | 35136 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6038 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 8301 | 0.050 |
Why?
|
Entropy | 1 | 2023 | 209 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6442 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Pain Measurement | 1 | 2010 | 3420 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18370 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19905 | 0.040 |
Why?
|
Sleep, REM | 1 | 2023 | 595 | 0.040 |
Why?
|
Electrodes | 1 | 2021 | 619 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4215 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13408 | 0.040 |
Why?
|
Rats | 2 | 2010 | 24260 | 0.040 |
Why?
|
Ankle | 1 | 2020 | 327 | 0.040 |
Why?
|
Sleep Stages | 1 | 2020 | 686 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12245 | 0.030 |
Why?
|
Risk Factors | 3 | 2021 | 72290 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 810 | 0.030 |
Why?
|
Cytokines | 1 | 2010 | 7322 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3271 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2011 | 63114 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10262 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2715 | 0.030 |
Why?
|
Mental Disorders | 1 | 2013 | 6600 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2013 | 8863 | 0.030 |
Why?
|
United States | 1 | 2019 | 69872 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2670 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3675 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5317 | 0.020 |
Why?
|
Arousal | 1 | 2015 | 1165 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12959 | 0.020 |
Why?
|
Critical Care | 1 | 2021 | 2647 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2010 | 972 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Animals | 2 | 2010 | 168757 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6756 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21746 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.010 |
Why?
|
Stroke | 1 | 2021 | 9981 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 12804 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9338 | 0.010 |
Why?
|
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_